The use of cisapride in children. The North American Society for Pediatric Gastroenterology and Nutrition

J Pediatr Gastroenterol Nutr. 1999 May;28(5):529-33. doi: 10.1097/00005176-199905000-00018.
No abstract available

Publication types

  • Guideline
  • Practice Guideline
  • Review

MeSH terms

  • Arrhythmias, Cardiac / chemically induced
  • Aryl Hydrocarbon Hydroxylases*
  • Cisapride / adverse effects
  • Cisapride / therapeutic use*
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme System / metabolism
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / therapeutic use*
  • Gastrointestinal Diseases / drug therapy
  • Humans
  • Infant
  • Infant, Newborn
  • Risk Factors

Substances

  • Gastrointestinal Agents
  • Cytochrome P-450 Enzyme System
  • Aryl Hydrocarbon Hydroxylases
  • CYP3A7 protein, human
  • Cytochrome P-450 CYP3A
  • Cisapride